Compounds > hydroxyflutamide
Page last updated: 2024-08-26

hydroxyflutamide and cycloheximide

hydroxyflutamide has been researched along with cycloheximide in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (60.00)18.2507
2000's2 (40.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mora, G; Muldoon, TG; Steinsapir, J1
Galosy, S; Gudmundsson, GO; Newcomer, B; Sridaran, R; Talamantes, F; Thordarson, G1
Fan, Z; Mendelsohn, J; Ye, D1
Lou, YR; Nazarova, N; Pennanen, P; Qiao, S; Tuohimaa, P1
Lou, YR; Nazarova, N; Talonpoika, R; Tuohimaa, P1

Other Studies

5 other study(ies) available for hydroxyflutamide and cycloheximide

ArticleYear
Effects of steroidal and non-steroidal antiandrogens on the androgen binding properties of the rat ventral prostate androgen receptor.
    Biochimica et biophysica acta, 1991, Aug-13, Volume: 1094, Issue:1

    Topics: Androgen Antagonists; Animals; Cycloheximide; Flutamide; Imidazoles; Imidazolidines; Kinetics; Male; Prostate; Rats; Receptors, Androgen

1991
Interaction of mouse placental lactogens and androgens in regulating progesterone release in cultured mouse luteal cells.
    Endocrinology, 1997, Volume: 138, Issue:8

    Topics: Androgen Receptor Antagonists; Androgens; Androstenedione; Animals; Aromatase Inhibitors; Cattle; Cells, Cultured; Cycloheximide; Dihydrotestosterone; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Estradiol; Estrogen Antagonists; Fadrozole; Female; Flutamide; Luteal Cells; Mice; Placental Lactogen; Pregnancy; Progesterone; Prolactin; Protein Synthesis Inhibitors; Rabbits; Testosterone

1997
Androgen and epidermal growth factor down-regulate cyclin-dependent kinase inhibitor p27Kip1 and costimulate proliferation of MDA PCa 2a and MDA PCa 2b prostate cancer cells.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 1999, Volume: 5, Issue:8

    Topics: Androgen Antagonists; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Cell Cycle Proteins; Cell Division; Cyclin-Dependent Kinase Inhibitor p27; Cyclin-Dependent Kinases; Cycloheximide; Dihydrotestosterone; Down-Regulation; Drug Synergism; Enzyme Inhibitors; Epidermal Growth Factor; ErbB Receptors; Flutamide; Humans; Male; Metribolone; Microtubule-Associated Proteins; Prostatic Neoplasms; Protein Synthesis Inhibitors; Receptors, Androgen; Testosterone Congeners; Trastuzumab; Tumor Cells, Cultured; Tumor Suppressor Proteins

1999
Inhibition of fatty acid synthase expression by 1alpha,25-dihydroxyvitamin D3 in prostate cancer cells.
    The Journal of steroid biochemistry and molecular biology, 2003, Volume: 85, Issue:1

    Topics: Androgen Antagonists; Anilides; Calcitriol; Cerulenin; Cycloheximide; Down-Regulation; Enzyme Inhibitors; Fatty Acid Synthases; Flutamide; Gene Expression Regulation, Neoplastic; Humans; Male; Nitriles; Oligonucleotide Array Sequence Analysis; Prostatic Neoplasms; Protein Synthesis Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tosyl Compounds; Tumor Cells, Cultured

2003
5alpha-dihydrotestosterone inhibits 1alpha,25-dihydroxyvitamin D3-induced expression of CYP24 in human prostate cancer cells.
    The Prostate, 2005, May-15, Volume: 63, Issue:3

    Topics: Androgen Receptor Antagonists; Androgens; Anilides; Calcitriol; Cycloheximide; Cytochrome P-450 Enzyme System; Dihydrotestosterone; Drug Interactions; Flutamide; Gene Expression Regulation, Enzymologic; Humans; Male; Nitriles; Prostatic Neoplasms; Protein Synthesis Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Steroid Hydroxylases; Tosyl Compounds; Tumor Cells, Cultured; Vitamin D3 24-Hydroxylase

2005